Curcumin: A potential therapeutic polyphenol, prevents noradrenaline- induced hypertrophy in rat cardiac myocytes

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 12, 2011, Pages 1604-1612

  Ahuja, Suchit ^a   Kohli, Shrey ^a   Krishnan, Shruti ^a   Dogra, Deepika ^a   Sharma, Dinesh ^b   Rani, Vibha ^a  

^a JAYPEE INSTITUTE OF INFORMATION TECHNOLOGY   (India)

^b Government Post Graduate College   (India)

Author keywords

cardiac hypertrophy; curcumin; GATA 4; noradrenaline; therapeutics

Indexed keywords

CURCUMIN; TRANSCRIPTION FACTOR GATA 4;

ANF GENE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; IMMUNOCYTOCHEMISTRY; MARKER GENE; NONHUMAN; PROTEIN CONTENT; PROTEIN DNA BINDING; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXICITY TESTING; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CARDIOMEGALY; CELL NUCLEUS; CELL SIZE; CELL SURVIVAL; CELLS, CULTURED; CURCUMIN; CYTOSOL; DNA; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; MYOCYTES, CARDIAC; NOREPINEPHRINE; RATS; RNA;

EID: 80855132955     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01363.x     Document Type: Article

References (28)

1. Ho CY,. Hypertrophic cardiomyopathy. Heart Fail Clin 2010; 6: 141-159.
2. Lorell BH, Carabello BA,. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000; 102: 470-479. (Pubitemid 30490688)
3. Beisvag V, et al,. Pathological and physiological hypertrophies are regulated by distinct gene programs. Eur J Cardiovasc Prev Rehabil 2009; 16: 690-697.
4. Molkentin JD, Dorn GW 2nd,. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001; 63: 391-426. (Pubitemid 32304323)
5. Frey N, Olson EN,. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003; 65: 45-79. (Pubitemid 38249147)
6. Akazawa H, Komuro I,. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 2003; 92: 1079-1088. (Pubitemid 36665853)
7. Sundaresan NR, et al,. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009; 119: 2758-2771.
8. Sugden PH,. Signalling pathways in cardiac myocyte hypertrophy. Ann Med 2001; 33: 611-622. (Pubitemid 34081499)
9. Palaniyandi SS, et al,. Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 2009; 82: 229-239.
10. Oka T, Komuro I,. Molecular mechanisms underlying the transition of cardiac hypertrophy to heart failure. Circ J 2008; 72 (Suppl A): A13-A16.
11. Sugden PH,. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res 1999; 84: 633-646. (Pubitemid 29157331)
12. Pikkarainen S, et al,. GATA transcription factors in the developing and adult heart. Cardiovasc Res 2004; 63: 196-207. (Pubitemid 38900834)
13. Xing W, et al,. Myocardin induces cardiomyocyte hypertrophy. Circ Res 2006; 98: 1089-1097.
14. Fiedler B, Wollert KC,. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes. Cardiovasc Res 2004; 63: 450-457. (Pubitemid 38970189)
15. Paul AG,. NF-κB: a novel therapeutic target for cancer. Eukaryon 2005; 1: 4-5.
16. Hsu CH, Cheng AL,. Clinical studies with curcumin. Adv Exp Med Biol 2007; 595: 471-480.
17. Ammon HP, Wahl MA,. Pharmacology of Curcuma longa. Planta Med 1991; 57: 1-7.
18. Epstein JA,. Currying favor for the heart. J Clin Invest 2008; 118: 850-852. (Pubitemid 351364593)
19. Morimoto T, et al,. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 2008; 118: 868-878. (Pubitemid 351364595)
20. Morimoto T, et al,. Novel heart failure therapy targeting transcriptional pathway in cardiomyocytes by a natural compound, curcumin. Circ J 2010; 74: 1059-1066.
21. Feng B, et al,. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 2008; 294: E1119-E1126.
22. Simpson P,. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response. J Clin Invest 1983; 72: 732-738. (Pubitemid 13051335)
23. Sreejit P, et al,. An improved protocol for primary culture of cardiomyocyte from neonatal mice. In Vitro Cell Dev Biol Anim 2008; 44: 45-50.
24. Plumb JA, et al,. Effects of the pH dependence of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989; 49: 4435-4440. (Pubitemid 19208340)
25. Lowry OH, et al,. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
26. Sindhu KV, et al,. Isolation of a library of target-sites for sequence specific DNA binding proteins from chick embryonic heart: a potential tool for identifying novel transcriptional regulators involved in embryonic development. Biochem Biophys Res Commun 2004; 323: 912-919. (Pubitemid 39243406)
27. Lampronti I, et al,. Inhibitory effects of Bangladeshi medicinal plant extracts on interactions between transcription factors and target DNA sequences. Evid Based Complement Alternat Med 2008; 5: 303-312.
28. Hatcher H, et al,. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65: 1631-1652.